FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

NCT00606528 · clinicaltrials.gov ↗

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

OTHER: No intervention

Sponsor

University Health Network, Toronto